🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LYE
$LYEL
🔒 US EquitiesLyell Immunopharma Inc
AVG HISTORICAL GAP
-1.18%
MAX GAP RECORD
-12.20%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LYEL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LYEL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-1.48%
|
| May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN) |
-2.42%
|
| Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE) |
+0.02%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
-3.57%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
-12.20%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
-0.74%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (AFTER CLOSE) |
+2.10%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+3.28%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.9%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (4)
📖 Intelligence Summary
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗